Article
Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2-low and HER2-zero breast cancer among Chinese females.
Cancer medicine - 1 Jul 2023
Zheng Lu, Zhang Yunmeng, Wang Zhipeng, Wang Huan, Hao Chunfang, Li Chenyang, Zhao Yanrui, Lyu Zhangyan, Song Fangfang, Chen Kexin, Huang Yubei, Song Fengju
Abstract excerpt
BACKGROUND: Traditional human epidermal growth factor receptor 2 (HER2)-negative breast cancer (BC) is recommended to be divided into HER2-low and HER2-zero subtypes due to different prognosis. However, few studies investigated their differences in clinical characteristics and prognosis among Chinese HER2-negative BC and their stratified differences by hormone receptor (HR), while fewer studies investigated their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.